Literature DB >> 30794227

What Is the Normal Trajectory of Interleukin-6 and C-reactive Protein in the Hours and Days Immediately After TKA?

Rajesh N Maniar1, Ganesh Navaneedhan, Sachin Ranvir, Adit R Maniar, Ankur Dhiman, Aniruddh Agrawal.   

Abstract

BACKGROUND: Some patients with early periprosthetic joint infection (PJI) can be treated successfully using open débridement with polyethylene exchange rather than two-stage revision; however, the challenge is to diagnose PJI early. In late infection, C-reactive protein (CRP) and interleukin-6 (IL-6) are elevated, but shortly after surgery, CRP is difficult to interpret because it may be elevated even in the absence of infection, and we know little about the normal trajectory of IL-6 immediately after arthroplasty. If a deviation of biomarkers from their normal trajectory is seen, it may help guide the clinician toward early knee aspiration. QUESTIONS/PURPOSES: We studied the normal trajectories of IL-6 and CRP in the immediate hours and days after uncomplicated TKA and examined whether one or the other normalizes more quickly.
METHODS: We studied serum IL-6 and CRP levels in 50 patients undergoing primary TKA at five time points: 12 hours preoperatively and postoperatively at 12 hours, 48 hours, 4 days, and 2 weeks. One surgeon operated on all patients using the same approach and postoperative management. The same laboratory methods were used each time. Results are presented as median and range. Repeated-measures analysis was done using Friedman's (nonparametric) test. No patient showed any clinical sign of infection during our study period. All patients were followed up until 1 year with no evidence of infection and good knee scores.
RESULTS: IL-6 showed a sharp rise from its baseline with a preoperative median value of 6 pg/mL (range, 3-17 pg/mL) to a peak of median value of 133 pg/mL (range, 15-359 pg/mL) at 12 hours postoperatively. At 48 hours, IL-6 had declined to a median value of 82 pg/mL (range, 12-309 pg/mL). At 4 days, it had further declined to a median value of 22 pg/mL (range, 5-67 pg/mL). At 2 weeks, IL-6 reached a median value of 7 pg/mL (range, 3-14 pg/mL), which was not different from the baseline median value with the numbers available (p = 0.455). CRP showed a gradual rise from its baseline preoperative median value of 2 mg/L (range, 1-17 mg/L) to a median value of 15 mg/L (range, 2-111 mg/L) at 12 hours postoperatively, which peaked at 48 hours to a median value of 125 mg/L (range, 22-247 mg/L). At 4 days postoperatively, CRP levels had declined to a median value of 69 mg/L (range, 21-234 mg/L). At 2 weeks, CRP had reached a median value of 12 mg/L (range, 1-72 mg/L), which was still higher than the baseline median value with available numbers (p < 0.001).
CONCLUSIONS: We found that after uncomplicated TKA, IL-6 showed a sharp rise to peak at 12 hours, then fell rapidly to near baseline levels by 4 days and returned to the baseline level at 2 weeks. CRP showed a gradual rise to peak at 48 hours, then fell gradually, remaining elevated at 4 days and higher than baseline level at 2 weeks. Future studies can help define more definitive thresholds for IL-6 and CRP; ideally, these should derive from large, multicenter studies. With such data, any deviation from a known normal trajectory can facilitate a quicker decision to perform knee aspiration to diagnose early PJI more promptly. LEVEL OF EVIDENCE: Level III, diagnostic study.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30794227      PMCID: PMC6345310          DOI: 10.1097/CORR.0000000000000332

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  12 in total

1.  C-reactive protein values and erythrocyte sedimentation rates after total hip and total knee arthroplasty.

Authors:  O Bilgen; T Atici; K Durak; M S Bilgen
Journal:  J Int Med Res       Date:  2001 Jan-Feb       Impact factor: 1.671

2.  Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty.

Authors:  Paul E Di Cesare; Eric Chang; Charles F Preston; Chuan-ju Liu
Journal:  J Bone Joint Surg Am       Date:  2005-09       Impact factor: 5.284

Review 3.  Interleukin-6 and the acute phase response.

Authors:  P C Heinrich; J V Castell; T Andus
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

Review 4.  The biology of interleukin-6.

Authors:  T Kishimoto
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

5.  Relationship of serum IL-6, C-reactive protein, erythrocyte sedimentation rate, and knee skin temperature after total knee arthroplasty: a prospective study.

Authors:  Sittisak Honsawek; Benjamad Deepaisarnsakul; Aree Tanavalee; Manoon Sakdinakiattikoon; Srihatach Ngarmukos; Kanok Preativatanyou; Piyanuch Bumrungpanichthaworn
Journal:  Int Orthop       Date:  2010-02-21       Impact factor: 3.075

Review 6.  Diagnosis of periprosthetic infection.

Authors:  Thomas W Bauer; Javad Parvizi; Naomi Kobayashi; Viktor Krebs
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

7.  Interleukin-6: a potential inflammatory marker after total joint replacement.

Authors:  D C Wirtz; K D Heller; O Miltner; K W Zilkens; J M Wolff
Journal:  Int Orthop       Date:  2000       Impact factor: 3.075

8.  C-reactive protein level after total hip and total knee replacement.

Authors:  J White; M Kelly; R Dunsmuir
Journal:  J Bone Joint Surg Br       Date:  1998-09

9.  Normative Temporal Values of CRP and ESR in Unilateral and Staged Bilateral TKA.

Authors:  Kwan Kyu Park; Tae Kyun Kim; Chong Bum Chang; Su Won Yoon; Kyoung Un Park
Journal:  Clin Orthop Relat Res       Date:  2008-01-03       Impact factor: 4.176

10.  Serum C-reactive protein levels after total hip and knee arthroplasty.

Authors:  R O Niskanen; O Korkala; H Pammo
Journal:  J Bone Joint Surg Br       Date:  1996-05
View more
  7 in total

Review 1.  Trend of Perioperative CRP (C-Reactive Protein) Levels in Non-Infected Total Knee Arthroplasty.

Authors:  Michele Mercurio; Olimpio Galasso; Filippo Familiari; Bruno Iannò; Carmine Fabio Bruno; Davide Castioni; Giorgio Gasparini
Journal:  Orthop Rev (Pavia)       Date:  2022-06-29

2.  CORR Insights®: Lower Success Rate of Débridement and Implant Retention in Late Acute versus Early Acute Periprosthetic Joint Infection Caused by Staphylococcus spp. Results from a Matched Cohort Study.

Authors:  Jacob M Drew
Journal:  Clin Orthop Relat Res       Date:  2020-06       Impact factor: 4.755

3.  Normal trajectory of Interleukin-6 and C-reactive protein in the perioperative period of total knee arthroplasty under an enhanced recovery after surgery scenario.

Authors:  Ze Yu Huang; Qiang Huang; Li Ying Wang; Yi Ting Lei; Hong Xu; Bin Shen; Fu Xing Pei
Journal:  BMC Musculoskelet Disord       Date:  2020-04-21       Impact factor: 2.362

4.  Low post-arthroplasty infection rate is possible in developing countries: long-term experience of local vancomycin use in Iran.

Authors:  Mohammad Naghi Tahmasebi; Arash Sharafat Vaziri; Fardis Vosoughi; Mohamad Tahami; Majid Khalilizad; Hamid Rabie
Journal:  J Orthop Surg Res       Date:  2021-03-17       Impact factor: 2.359

5.  Interrelationship of MMP-9, Proteoglycan-4, and Inflammation in Osteoarthritis Patients Undergoing Total Hip Arthroplasty.

Authors:  Hannah Slovacek; Rajan Khanna; Pavel Poredos; Peter Poredos; Mateja Jezovnik; Debra Hoppensteadt; Jawed Fareed; William Hopkinson
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

6.  Association between Preoperative Long-Chain Polyunsaturated Fatty Acids and Oxidative Stress Immediately after Total Knee Arthroplasty: A Pilot Study.

Authors:  Yusuke Kubo; Masae Ikeya; Shuhei Sugiyama; Rie Takachu; Maki Tanaka; Takeshi Sugiura; Kaori Kobori; Makoto Kobori
Journal:  Nutrients       Date:  2021-06-19       Impact factor: 5.717

7.  Neutrophil to lymphocyte ratio as a predictor for diagnosis of early Periprosthetic joint infection.

Authors:  Bao-Zhan Yu; Jun Fu; Wei Chai; Li-Bo Hao; Ji-Ying Chen
Journal:  BMC Musculoskelet Disord       Date:  2020-10-27       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.